why choose us

Clinical Trials Search

Showing 12,480 of 132,366 result(s)
Tumor-Derived FGF19

Status: Completed

Condition: Colorectal Cancer

Interventions:

Date: 2023-05-03

A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN

Status: COMPLETED

Condition: Immunoglobulin A Nephropathy

Interventions: Target dose of 400 mg daily

Date: 2023-05-03

Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women

Status: COMPLETED

Condition: Migraine

Interventions: Sumatriptan, treximet (sumatriptan;naproxen combination), zolmitriptan, naratriptan, rizatriptan, almotriptan, eletriptan, and frovatriptan.

Date: 2023-05-03

Optimal Dosage of Remifentanil for Vertebroplasty

Status: COMPLETED

Condition: Remifentanil

Interventions: Different initial remifentanil effect-site concentration

Date: 2023-05-03

Efficacy of External Application of Rosemary Oil in Patients With Chemotherapy-Induced Peripheral Neuropathy: a Feasibility Study

Status: COMPLETED

Condition: Chemotherapy-induced Peripheral Neuropathy (CIPN)

Interventions: Application of Rosemary oil (10%) to both hands and both feet once a day for 24 weeks

Date: 2023-05-03

Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors

Status: COMPLETED

Condition: Arthritis, Rheumatoid

Interventions:

Date: 2023-05-03

Efficacy of External Application of Rosemary Oil in Patients With Chemotherapy-Induced Peripheral Neuropathy: a Feasibility Study

Status: COMPLETED

Condition: Chemotherapy-induced Peripheral Neuropathy (CIPN)

Interventions: Application of Rosemary oil (10%) to both hands and both feet once a day for 24 weeks

Date: 2023-05-03

Implementation of SGLT-2 Inhibitors in Patients With Heart Failure Through a New Digital Strategy

Status: COMPLETED

Condition: Heart Failure

Interventions: A digital letter with evidence-based information about the newly approved heart failure therapy option, SGLT-2 inhibitors.
The letter will also i

Date: 2023-05-03

Tumor-Derived FGF19

Status: COMPLETED

Condition: Colorectal Cancer
Breast Cancer
Healthy

Interventions:

Date: 2023-05-03

Measuring rTMS-induced Neuroplasticity With EEG Steady-state Visual-evoked Potentials

Status: COMPLETED

Condition: Visual Cortical Plasticity
Repetitive Transcranial Magnetic Stimulation
Visual Attention

Interventions: DEVICE: repetitive transcranial magnetic stimulation - Repetitive TMS targeted by neuronavigation to left lower visual field of primary visual cortex.

Date: 2023-05-02